Study Stopped
The current study was prematurely terminated as part of a strategic decision to consolidate resources and incorporate the Trinity implant into another ongoing PMCF study which was initiated to meet updated regulatory requirements.
Observational Study to Collect Safety Data and PROMs on Primary THA
1 other identifier
observational
116
1 country
1
Brief Summary
This observational study is designed to collect safety data and PROMs on retrospective primary total hipa arthroplasty surgeries with Trinity cup and Meije Duo cementless hip system
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 19, 2024
CompletedFirst Submitted
Initial submission to the registry
July 15, 2024
CompletedFirst Posted
Study publicly available on registry
July 25, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2025
CompletedJuly 9, 2025
July 1, 2025
1.2 years
July 15, 2024
July 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of hip functional performance
Improvement of Oxford Hip Score (OHS)
2 years
Secondary Outcomes (5)
Confirmation of safety of the study devices
2 years
Evaluation of outcome after hip arthroplasty
2 years
Evaluation of clinical outcomes
2 years
Assessment of health-related quality of life
2 years
Assessment of patient's satisfaction
2 years
Interventions
Subjects clinically suitable for a primary THR surgery with Trinity cup and Meije Duo cementless femoral stem.
Eligibility Criteria
Patients who have undergone to a THA with Trinity cup and Meije Duo cementless hip will be invited to participate in this study. An initial review of the medical database of all Corin Trinity cup procedures performed in the selected study site will be conducted to assess the number of retrospective patients potentially available to join the study. A first contact with the patient will occur telephonically or via mail to explain the study and invite them to join.
You may qualify if:
- Both genders.
- Adult subjects.
- Subjects who received a primary THR with Trinity cup and Meije Duo cementless femoral stem.
- The subject is willing to comply with the required follow-up visits as per protocol.
- The subject has signed a Patient Informed Consent Form (PICF), specific to this study, and approved by the local EC.
You may not qualify if:
- Subjects under guardianship.
- Subjects in the opinion of the Investigator/ investigative team who will be unable to comply with study procedures (Examples: recent psychotic or mania disorders, alcohol, drug or substance abusers) and/or those unable for any medical or other reason to comply with study procedures/visits.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Corinlead
Study Sites (1)
CH Valenciennes
Valenciennes, 59300, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charles BERTON, MD
CH VALENCIENNES
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2024
First Posted
July 25, 2024
Study Start
April 19, 2024
Primary Completion
June 20, 2025
Study Completion
June 20, 2025
Last Updated
July 9, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share